Mepolizumab, a biologic approved for asthma, is not currently approved for COPD, but data from a 2017 study showed a trend ...

More than 11 million people in the United States are living with chronic obstructive pulmonary disease (COPD), including more ...

GSK plc GSK announced that the FDA has accepted its regulatory filing, seeking the approval of a new indication for Nucala ...

Benralizumab can be used for the treatment of acute eosinophilic exacerbations of asthma and chronic obstructive pulmonary ...

I was diagnosed with COPD last year after struggling with multiple symptoms. I quit smoking over 10 years ago, but I'm dealing with the effects of it ...

Benralizumab can be used for the treatment of acute eosinophilic exacerbations of asthma and chronic obstructive pulm ...

The FDA has accepted for review the BLA for mepolizumab as an add-on maintenance treatment for eosinophilic COPD.

Several businesses and nonprofits have opened or will open new medical-related facilities in south central Pennsylvania. The ...

British drug maker GSK plc (GSK, GSK.L) announced Monday that the U.S. Food and Drug Administration has accepted for review, data ...

In recent weeks there has been a buzz around a new treatment breakthrough: benralizumab, which in a study published in the ...

The US Food and Drug Administration (FDA) has accepted a submission from GSK to review a new indication of Nucala ...

Initiating oseltamivir on the same day as hospital admission reduced the risk for severe clinical outcomes in adults ...